title: Cutting edge: novel vaccination modality provides significant protection against mucosal infection by highly pathogenic simian immunodeficiency virus.
abstract: Vaccine-induced protection against infection by HIV or highly pathogenic and virulent SIV strains has been limited. In a proof-of-concept study, we show that a novel vaccine approach significantly protects rhesus macaques from mucosal infection by the highly pathogenic strain SIVmac251. We vaccinated three cohorts of 12 macaques each with live, irradiated vaccine cells secreting the modified endoplasmic reticulum chaperone gp96-Ig. Cohort 1 was vaccinated with cells secreting gp96(SIV)Ig carrying SIV peptides. In addition, Cohort 2 received recombinant envelope protein SIV-gp120. Cohort 3 was injected with cells secreting gp96-Ig (no SIV Ags) vaccines. Cohort 2 was protected from infection. After seven rectal challenges with highly pathogenic SIVmac251, the hazard ratio was 0.27, corresponding to a highly significant, 73% reduced risk for viral acquisition. The apparent success of the novel vaccine modality recommends further study.
authors: Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
authors: Natasa
authors: N
authors: Strbo
authors: Monica
authors: M
authors: Vaccari
authors: Savita
authors: S
authors: Pahwa
authors: Michael A
authors: MA
authors: Kolber
authors: Melvin N
authors: MN
authors: Doster
authors: Eva
authors: E
authors: Fisher
authors: Louis
authors: L
authors: Gonzalez
authors: Donald
authors: D
authors: Stablein
authors: Genoveffa
authors: G
authors: Franchini
authors: Eckhard R
authors: ER
authors: Podack
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D015331:Cohort Studies; D005260:Female; D057809:HEK293 Cells; D006801:Humans; D007274:Injections, Intraperitoneal; D007413:Intestinal Mucosa / Q000276:immunology* / Q000473:pathology / Q000821:virology; D008253:Macaca mulatta; D008297:Male; D008562:Membrane Glycoproteins / Q000008:administration & dosage* / Q000627:therapeutic use*; D009092:Mucous Membrane / Q000276:immunology / Q000821:virology; D012002:Rectal Diseases / Q000276:immunology / Q000517:prevention & control / Q000821:virology; D018449:SAIDS Vaccines / Q000008:administration & dosage* / Q000276:immunology; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control*; D015302:Simian Immunodeficiency Virus / Q000276:immunology* / Q000472:pathogenicity; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000473:pathology / Q000821:virology
chemical_list: D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D008562:Membrane Glycoproteins; D018449:SAIDS Vaccines; C053387:endoplasmin
references: Mucosal Immunol. 2008 Nov;1(6):497-507
references: 19079217
references: Nature. 2012 Jan 04;482(7383):89-93
references: 22217938
references: J Immunol. 2007 Aug 15;179(4):2310-7
references: 17675492
references: Nat Immunol. 2000 Aug;1(2):151-5
references: 11248808
references: Vaccine. 2011 Apr 12;29(17):3310-9
references: 21382487
references: Mucosal Immunol. 2010 Mar;3(2):182-92
references: 19924120
references: Nat Med. 2010 Mar;16(3):319-23
references: 20173752
references: Vaccine. 2011 Mar 21;29(14):2619-25
references: 21277409
references: J Immunol. 1999 Nov 15;163(10):5178-82
references: 10553037
references: J Biol Chem. 2002 Jun 7;277(23):20847-53
references: 11912201
references: J Virol. 2011 Dec;85(23):12399-409
references: 21917950
references: Nat Immunol. 2012 Apr 18;13(5):423-7
references: 22513323
references: Nature. 2009 Jan 1;457(7225):87-91
references: 18997770
references: Nat Med. 2009 Mar;15(3):293-9
references: 19219024
references: Nature. 2011 May 26;473(7348):523-7
references: 21562493
references: Nature. 2008 May 29;453(7195):667-71
references: 18449194
references: Eur J Immunol. 2000 Aug;30(8):2211-5
references: 10940912
references: N Engl J Med. 2012 Apr 5;366(14):1275-86
references: 22475592
references: N Engl J Med. 2009 Dec 3;361(23):2209-20
references: 19843557
references: Sci Transl Med. 2011 May 4;3(81):81ra36
references: 21543722
references: J Exp Med. 1995 Sep 1;182(3):885-9
references: 7650492
references: J Immunol. 2009 Mar 15;182(6):3718-27
references: 19265150